Orange and Deutsche Telekom Capital Partners both chipped in as the cybersecurity software provider looks to ramp up hiring.

Propel Venture Partners returned to help the employee benefits platform developer hike its total funding to more than $70m.

Globant and Mercado Libre both invested having partnered the coding education provider on a two-year programme about to launch.

Retinal disease drug developer Gyroscope Therapeutics has raised series C funding from investors including Fosun Pharma.

The solid tumour therapy developer secured $21.9m from investors including Dai-ichi Life, Binex, Bigen and Shibuya Kogyo.

The open-source software manager was valued above $800m in a round that included new corporate backer Salesforce Ventures.

Alphabet's CapitalG unit contributed to a series C round valuing the identity verification network provider at $1.5bn.

The Alphabet, Virgin and Access Industries-backed cryptocurrency technology provider hiked its valuation to $5.2bn in a series C announced just five weeks after its last round.

The event community platform developer secured the series C funding at a $325m valuation and plans to more than double headcount this year.

The WuXi AppTec-backed infectious disease therapeutics developer has closed a series C round featuring various investment managers and Singapore's sovereign wealth fund.